Keiji Hirata

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer

Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura et al. · Nature Medicine · 2023 · 430 citations · Full text

Surgical Oncology, Oncology, Cancer Epidemiology +15

Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.

Keiji Hirata, N Horikoshi, K Aiba et al. · PubMed · 1999 · 227 citations

Medicinal Chemistry, Oncology, Health Sciences +15

Nuclear and cytosolic calcium are regulated independently

M. Fátima Leite, Edwin C. Thrower, Wihelma Echevarría et al. · Proceedings of the National Academy of Sciences · 2003 · 203 citations · Full text

ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa et al. · Nature Medicine · 2024 · 132 citations · Full text

Interim Analysis, Prognostic Biomarkers, Surgical Oncology +14

Loss of Inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis

Kazunori Shibao, Keiji Hirata, Marie E. Robert et al. · Gastroenterology · 2003 · 124 citations · Full text

Signal Transduction, Biochemistry, Inositol 1,4,5-Trisphosphate Receptors +13